BACKGROUND: Cholestatic liver diseases can be caused by genetic defects, drug toxicities, hepatobiliary malignancies or obstruction of the biliary tract. Cholestasis leads to accumulation of bile acids (BAs) in hepatocytes. Direct toxicity of BAs is currently the most accepted hypothesis for cholestatic liver injury. However, information on which bile acids are actually accumulating during cholestasis is limited. AIM: To assess the BA composition in liver and serum after bile duct ligation (BDL) in male C57Bl/6 mice between 6 h and 14 days and evaluate toxicity of the most abundant BAs. RESULTS: Bile acid concentrations increased in liver (27-fold) and serum (1400-fold) within 6 h after surgery and remained elevated up to 14 days. BAs in livers of BDL mice became more hydrophilic than sham controls, mainly because of increased 6β-hydroxylation and taurine conjugation. Among the eight unconjugated and 16 conjugated BAs identified in serum and liver, only taurocholic acid (TCA), β-muricholic acid (βMCA) and TβMCA were substantially elevated representing >95% of these BAs over the entire time course. Although glycochenodeoxycholic acid and other conjugated BAs increased in BDL animals, the changes were several orders of magnitude lower compared with TCA, βMCA and TβMCA. A mixture of these BAs did not cause apoptosis or necrosis, but induced inflammatory gene expression in cultured murine hepatocytes. CONCLUSION: The concentrations of cytotoxic BAs are insufficient to cause hepatocellular injury. In contrast, TCA, βMCA and TβMCA are able to induce pro-inflammatory mediators in hepatocytes. Thus, BAs act as inflammagens and not as cytotoxic mediators after BDL in mice.
BACKGROUND:Cholestatic liver diseases can be caused by genetic defects, drug toxicities, hepatobiliary malignancies or obstruction of the biliary tract. Cholestasis leads to accumulation of bile acids (BAs) in hepatocytes. Direct toxicity of BAs is currently the most accepted hypothesis for cholestatic liver injury. However, information on which bile acids are actually accumulating during cholestasis is limited. AIM: To assess the BA composition in liver and serum after bile duct ligation (BDL) in male C57Bl/6 mice between 6 h and 14 days and evaluate toxicity of the most abundant BAs. RESULTS:Bile acid concentrations increased in liver (27-fold) and serum (1400-fold) within 6 h after surgery and remained elevated up to 14 days. BAs in livers of BDL mice became more hydrophilic than sham controls, mainly because of increased 6β-hydroxylation and taurine conjugation. Among the eight unconjugated and 16 conjugated BAs identified in serum and liver, only taurocholic acid (TCA), β-muricholic acid (βMCA) and TβMCA were substantially elevated representing >95% of these BAs over the entire time course. Although glycochenodeoxycholic acid and other conjugated BAs increased in BDL animals, the changes were several orders of magnitude lower compared with TCA, βMCA and TβMCA. A mixture of these BAs did not cause apoptosis or necrosis, but induced inflammatory gene expression in cultured murine hepatocytes. CONCLUSION: The concentrations of cytotoxic BAs are insufficient to cause hepatocellular injury. In contrast, TCA, βMCA and TβMCA are able to induce pro-inflammatory mediators in hepatocytes. Thus, BAs act as inflammagens and not as cytotoxic mediators after BDL in mice.
Authors: Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Gernot Zollner; Martin Wagner; Hanns-Ulrich Marschall; Kurt Zatloukal; Helmut Denk Journal: J Hepatol Date: 2005-03 Impact factor: 25.083
Authors: Douglas J Turner; Samuel M Alaish; Tongtong Zou; Jaladanki N Rao; Jian-Ying Wang; Eric D Strauch Journal: Ann Surg Date: 2007-03 Impact factor: 12.969
Authors: Martin Wagner; Gernot Zollner; Peter Fickert; Judith Gumhold; Dagmar Silbert; Andrea Fuchsbichler; Jaspreet S Gujral; Kurt Zatloukal; Helmut Denk; Hartmut Jaeschke; Michael Trauner Journal: Drug Metab Dispos Date: 2007-06-18 Impact factor: 3.922
Authors: Philip Wintermeyer; Chao-Wen Cheng; Stephan Gehring; Beth L Hoffman; Martin Holub; Laurent Brossay; Stephen H Gregory Journal: Gastroenterology Date: 2008-11-01 Impact factor: 22.682
Authors: Peter Fickert; Martin Wagner; Hanns-Ulrich Marschall; Andrea Fuchsbichler; Gernot Zollner; Oleksiy Tsybrovskyy; Kurt Zatloukal; Jie Liu; Michael P Waalkes; Cathleen Cover; Helmut Denk; Alan F Hofmann; Hartmut Jaeschke; Michael Trauner Journal: Gastroenterology Date: 2006-02 Impact factor: 22.682
Authors: Hao Yin; Roman L Bogorad; Carmen Barnes; Stephen Walsh; Iris Zhuang; Hidenori Nonaka; Vera Ruda; Satya Kuchimanchi; Lubomir Nechev; Akin Akinc; Wen Xue; Marino Zerial; Robert Langer; Daniel G Anderson; Victor Koteliansky Journal: J Hepatol Date: 2015-11-30 Impact factor: 25.083
Authors: Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke Journal: Toxicol Appl Pharmacol Date: 2015-01-28 Impact factor: 4.219
Authors: Kate M O'Brien; Katryn M Allen; Cheryl E Rockwell; Keara Towery; James P Luyendyk; Bryan L Copple Journal: Am J Pathol Date: 2013-09-05 Impact factor: 4.307
Authors: Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke Journal: Toxicol Appl Pharmacol Date: 2013-10-03 Impact factor: 4.219